Meet Alfa Cytology at the Cancer R&D 2024, Nov 18-20, 2024. We look forward to connecting with you and providing expert solutions for your cancer drug development projects.
Learn MoreChemokine receptors and their ligands are widely involved in the pathophysiological process of tumor growth and progression, making them attractive therapeutic targets to explore. Alfa Cytology offers tailored chemokine analysis services to support your research.
Chemokines are chemotactic cytokines that govern the migration, adhesion and cell-cell interaction of immune cells. There are approximately 50 known chemokines categorized into four primary classes based on the positioning of the first two cysteine residues in their primary protein structure, namely the C, the CC, the CXC and the CX3C chemokines.
Chemokine Family | Chemokine receptors | Ligands |
CC | CCR1 | CCL3, CCL4, CCL5, CCL7, CCL8, CCL13, CCL14, CCL15, CCL16, CCL23 |
CCR2 | CCL2, CCL7, CCL8, CCL13, CCL16 | |
CCR3 | CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL15, CCL16, CCL23, CCL24, CCL26, CCL28 | |
CCR4 | CCL3, CCL5, CCL17, CCL22 | |
CCR5 | CCL2, CCL3, CCL4, CCL5, CCL8, CCL11, CCL13, CCL14, CCL16 | |
CCR8 | CCL1, CCL4, CCL16, CCL17, CCL18 | |
CXC | CXCR1 | CXCL1, CXCL17 |
CXCR2 | CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL8 | |
CXCR3 | CXCL4, CXCL9, CXCL10, CXCL11, CXCL13 | |
C | XCR1 | XCL1, XCL2 |
CX3C | CX3CR1 | CX3CL1 |
Chemokines are widely engaged in carcinogenesis and exhibit a bidirectional role in the development of brain tumors, including immune evasion, tumor proliferation, angiogenesis and metastasis. Chemokines such as CXCL10 chemokine axes can direct immune cell trafficking and then guide the spatial organization and anti-tumor immune response in the brain tumor microenvironment. On the other hand, other chemokine systems such as CCR8 chemokine axes can facilitate the differentiation and migration of immunosuppressive cells and tumor-associated macrophages, contributing to a pro-tumorigenic microenvironment in brain tumors.
Fig.1 Chemokines in pro-tumor immunity. (Bule P., et al., 2021)
Equipped with a high throughput flow cytometer, Alfa Cytology can provide advanced brain tumor related chemokine analysis services to our clients.
Chemokine Profiling
Specializing in qualitative and quantitative chemokine analyses, we employ techniques like ELISA and cytometric bead array immunoassays to assess a diverse array of chemokines.
In Situ Chemokines Analysis
In situ chemokine detection services encompass probe synthesis, FISH protocol design, imaging techniques and data analysis tailored specifically to support your brain tumor research .
Cell Signaling Pathway Analysis
PPI network analysis, GO enrichment analysis and KEGG signaling pathway analysis are offered to explore the correlation between prognosis-related chemokines and immune cell infiltration.
Cell Migration & Invasion Assays
Validated transwell assays and scratch assays are offered for precise evaluation of how various chemokines influence cell invasion and migration with high effectiveness.
The complex interactions between chemokine receptors and their ligands require an in-depth understanding of brain tumor microenvironment biology. Alfa Cytology provides professional chemokine analysis services tailored to your specific needs. Please feel free to contact us to discuss any project related to chemokines in brain tumors.
Reference